Maternal mortality ratio (per 100 000 live births) - Country reported estimates
Smear-positive tuberculosis case-detection rate (%)
Prevalence of smoking any tobacco product among adults (&#8805;15 years) (%)
Household air pollution  attributable deaths per 100'000 children under 5 years
Household air pollution  attributable DALYs per 100'000 children under 5 years
UV radiation attributable DALYs per 100'000 capita
Radiotherapy units (per 1 000 000 population)
Nursing and midwifery personnel density (per 10 000 population)
Number of dentistry personnel
Number of nursing and midwifery personnel
Dentistry personnel density (per 10 000 population)
Total density per 100 000 population: Health posts
Total density per 100 000 population: Health centres
Total density per million population: Radiotherapy units
National guidelines, policies or recommendations on the procurement of medical devices
Cellular subscribers (per 100 population)
Number of national population surveys - child anthropometry
Number of national population surveys - maternal mortality
Number of under-five deaths from malaria
Distribution of causes of death among children aged <5 years (%) - Other diseases
Distribution of causes of death among children aged <5 years (%) - Pneumonia
Distribution of causes of death among children aged <5 years (%) - Diarrhoea
Distribution of causes of death among children aged <5 years (%) - Malaria
Distribution of causes of death among children aged <5 years (%) - Injuries
Distribution of causes of death among children aged <5 years (%) - HIV/AIDS
Distribution of causes of death among children aged <5 years (%) - Measles
Distribution of causes of death among children aged <5 years (%) - Neonatal sepsis
Distribution of causes of death among children aged <5 years (%) - Prematurity
Distribution of causes of death among children aged <5 years (%) - Birth asphyxia
Distribution of causes of death among children aged <5 years (%) - Congenital anomalies
Website of the formal Medicines Regulatory Authority
Number of registered pharmaceutical products
Licensing private pharmacies obligatory
Legal provisions control promoting and advertising of prescription medicine
Legal provisions exist requiring authorization for conducting Clinical Trials by the MRA
Pregnant women receive free medicines
Social (health) fund is providing at least partial medicine coverage
National Standard Treatment Guidelines specific to paediatric conditions exist
Existence of National strategy to contain antimicrobial resistance
Tuberculosis - new and relapse cases
Antenatal care attendees who were positive for syphilis (%)
Women accessing antenatal care (ANC) services who were tested for syphilis (%)
Annual incidence of dracunculiasis cases
Net primary school enrolment ratio (%)
Malaria outpatient cases
Malaria attributed deaths
Health warnings on other smoked tobacco packaging must be written in the principal language(s) of the country
Health warnings on other smoked tobacco packaging must include a photograph or graphic
Daily users of any smokeless tobacco product (crude rate)
Exposure to smoke at home
Exposure to smoke outside home
Percentage of principal display area mandated to be covered by health warnings - back of other smoked tobacco packaging
Health warnings appear on each other smoked tobacco package and any outside packaging and labelling used in the retail sale
Health warnings on other smoked tobacco packaging describe the harmful effects of tobacco use on health
Font style, font size and colour of health warnings are mandated for other smoked tobacco packaging
Repeating interval for survey of youth (years)
Current smokers of cigarettes (youth rate)
Nicotine replacement therapy - place available
Bupropion - legally sold
Bupropion - place available
Raised total cholesterol (&#8805; 6.2 mmol/L) (age-standardized estimate)
Mean BMI (kg/m&#xb2;) (crude estimate)
Mean Total Cholesterol (crude estimate)
Mean Total Cholesterol (age-standardized estimate)
Mean fasting blood glucose (mmol/l) (crude estimate)
Mean systolic blood pressure (crude estimate)
Age-standardized death rates, poisoning, per 100,000
Age-standardized death rates, violence, per 100,000
Age-standardized death rates, falls, per 100,000
Treatment, services
Counselling
Production in 1000s hectolitres
Imports in 1000s hectolitres
Sales of beer in 1000s hectolitres
Exports of spirits in 1000s hectolitres
Exports of wine (grape) in 1000s hectolitres
Sales of wine in 1000s hectolitres
Exports of beer (barley) in 1000s hectolitres
Point prevalence (%), drug use disorders, 15+ years
Data on substance use disorders disseminated in national annual reports
Drug courts
Programmes diverting clients from the justice system towards treatment
Legislative provision for treatment and rehabilitation of substance use disorders
Guidelines on the pharmacological treatment of substance use disorders
Treatment slots for alcohol and drug use disorders, outpatient, per 10 000
Governement benefits for persons with substance use disorders
Treatment system for substance use disorders
Sector for residential long-term rehabilitation of alcohol use disorders
Specialized treatment services for substance use disorders and TB
Length of stay for inpatient detoxification, days
Government benefits for drug use disorders, subsidy or disability pension
Open access services for substance use disorders
Pharmacotherapy used for the management of alcohol withdrawal
Pharmacotherapy used for the management of benzodiazepine withdrawal
Pharmacotherapy used for the management of cannabis withdrawal
Age-standardized death rates, breast cancer, per 100,000
Age-standardized death rates, cerebrovascular disease, per 100,000
Age-standardized death rates, diabetes mellitus, per 100,000
Age-standardized death rates, alcohol use disorders, per 100,000
Age-standardized death rates, fires, per 100,000
Age-standardized death rates, liver cirrhosis, per 100,000
Age-standardized death rates, oesophagus cancer, per 100,000
Age-standardized death rates, mouth and oropharynx cancer, per 100,000
Age-standardized death rates, other unintentional injuries, per 100,000
Age-standardized death rates, prematurity and low birth rate, per 100,000
Age-standardized death rates, road traffic accidents, per 100,000
Age-standardized DALYs, alcohol use disorders, per 100,000
Age-standardized DALYs, cerebrovascular disease, per 100,000
Age-standardized DALYs, diabetes mellitus, per 100,000
Age-standardized DALYs, liver cancer, per 100,000
Age-standardized DALYs, other unintentional injuries, per 100,000
Age-standardized DALYs, poisoning, per 100,000
Age-standardized DALYs, road traffic accidents, per 100,000
Age-standardized DALYs, self-inflicted injury, per 100,000
Age-standardized DALYs, violence, per 100,000
Groups and agencies for the prevention of substance use disorders
NGOs for alcohol use disorders
Clinical supervision of health care staff
Self-help groups for substance use disorders
NGOs for drug use disorders
Age-standardized DALYs, alcohol and drug use disorders, per 100 000
Methadone provision in clinical and community-based settings
Buprenorphine provision in clinical and community-based settings
Prescription requirements for methadone
Supervision requirements for buprenorphine/naloxone administration
Prescription requirements for buprenorphine/naloxone
Buprenorphine/naloxone provision in clinical and community-based settings
Programmes for the prevention of substance use disorders for special populations
Prevention activities for substance use disorders, main focus
Harm reduction programmes for IDUs
Budget line for substance use disorder prevention
Methadone formulation used for the treatment of opiod dependence
Buprenorphine used for detoxification or maintenance
Opioid agonist pharmacotherapy for the treatment of opioid dependence (maintenance)
Substance use policy at the national level, level of integration
Hospital discharges, alcohol-related injuries and poisoning, per 100,000
Treatment admissions (inpatient), alcohol dependence, per 100,000
Alcohol-related injury mortality, per 1,000
System for monitoring alcohol-related harm
Data collection on alcohol-related health indicators
Persons with alcohol use disorders receiving treatment (%)
Counselling to children in families with alcohol problems
Prevention/counselling at workplaces for those with alcohol problems
Counselling to pregnant women with alcohol problems
Interventions/projects actively involving young people and civil society
Educational programmes involving target groups in school curriculum
Human development index rank
New cases: pulmonary smear-negative
New cases: pulmonary smear unknown/not done
Retreatment cases: treatment after failure (pulmonary smear and/or culture positive)
Retreatment cases: treatment after default (pulmonary smear and/or culture positive)
Retreatment cases: other
Smear-positive tuberculosis treatment-success rate (%)
Treatment success rate for new pulmonary smear-negative and extrapulmonary tuberculosis cases
ICT Development Index (IDI)
Importance of measures for enhancing compliance with age limits
Prices for alcoholic beverages (average, US$)
Mental health policy
Confirmed cases of MDR-TB
Health technology (medical device) national policy
Type of nomenclature system
Types of lists recommending health technology for high burden diseases
Total density per 100 000 population: District/rural hospitals
Total density per million population: Gamma camera or Nuclear medicine
Coordination
Household air pollution attributable deaths per 100'000 capita
Civil registration coverage of causes of deaths (%)
Ambient air pollution in urban areas (Annual PM<sub>10</sub> [&#956;g/m<sup>3</sup>])
Percent of urban inhabitants living in cities covered by PM measurements
Total density per 100 000 population: Specialized hospitals
Total density per million population: Magnetic Resonance Imaging
Total density per million population: Computed tomography units
Total density per million population: Linear Accelerator
Unit in the Ministry of Health responsible for the management of medical devices
Availability of technical specifications of medical devices to support procurement or donations
Number of national population surveys - child mortality
Number of national population surveys -  HIV prevalence
Total Pharmaceutical Expenditure (millions US$)
Existence of formal Medicines Regulatory Authority
Market Authorization for all pharmaceutical products required
National Quality Control Laboratory exists
Ban on Direct to Consumer Pharmaceutical Advertising
All medicines included in the EML
System in place to monitor prices of medicines
Standard Treatment Guidelines for common illnesses are made by Ministry of Health
National Medicines Information Center provides information on medicines
Percentage of principal display area mandated to be covered by health warnings - front and back of other smoked tobacco packaging
Percentage of principal display area mandated to be covered by health warnings - front of other smoked tobacco packaging
Specific health warnings are mandated for other smoked tobacco packaging
Number of health warnings approved by the law for other smoked tobacco packaging
Smoking cessation support is available in health clinics or other primary care facilities
Smoking cessation support is available in offices of health professionals
Smoking cessation support is available in the community
Fines on the patron
Dedicated funds for enforcement
Citizen complaints and investigations
Raised total cholesterol (>= 5.0 mmol/L) (crude estimate)
Raised total cholesterol (>= 5.0 mmol/L) (age-standardized estimate)
Income level
Age-standardized death rates, drownings, per 100,000
Information, education, prevention
Perceived trend in sales
Point prevalence (%), alcohol use disorders, 15+ years
National survey on substance use among children and adolescents
Epidemiological data collection system for substance use disorders
Service delivery data collection system for substance use disorders
Budget line for substance use disorder treatment
Policy documents on the pharmacological treatment of substance use disorders
Sector for inpatient detoxification of drug use disorders
Sector for the treatment of alcohol-induced psychoses and other alcohol-induced psychiatric conditions
Sector for inpatient detoxification of alcohol use disorders
Treatment setting for substance use disorders, most common
Sector for residential long-term rehabilitation of drug use disorders
Length of stay for inpatient short-term treatment, days
Financing method for substance use disorder treatment
Commencement of treatment with opioid agonists
Age-standardized death rates, colon and rectum cancers, per 100,000
Age-standardized DALYs, breast cancer, per 100,000
Age-standardized DALYs, colon and rectum cancers, per 100,000
Psychoactive substance causing entry into treatment
Age-standardized death rates, alcohol and drug use disorders, per 100 000
Prescription requirements for buprenorphine
Government unit for substance use disorder prevention
Methadone used for detoxification or maintenance
Buprenorphine/naloxone used for detoxification or maintenance
Methadone used for the treatment of opioid dependence
Substance use policy at the national level
Minimum legal drinking age
Community-based interventions/projects involving stakeholders
Public-funded alcohol research/monitoring programmes
Public funds designated for alcohol research/monitoring programmes, in Euros
National treatment policy for alcohol use disorders
Server training on a regular basis
New cases: other
Mental health plan
Percentage of individuals using the Internet
New types of alcoholic beverages emerging
National alcohol policy specifically involves young people activities
Excise tax as a per cent of the retail price of alcoholic beverages
Dracunculiasis certification status of countries at the beginning of the year
Antiretroviral therapy coverage among people with HIV infection eligible for ART according to 2010 guidelines (%)
Estimated number of people eligible for antiretroviral therapy according to 2010 guidelines
Procurement of medical devices carried out at the national level
Availability of national list of approved medical devices for procurement or reimbursement
Use of nomenclature system
Availability of national standards or recommended lists of medical devices
Legislation
Surveillance
Zoonosis
Chemical
Human resources
Points of entry
Alcohol, estimate of five-year change in recorded per capita (15+) consumption 2006-2010
Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) with 95%CI
Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI
Low-birth-weight newborns (%)
Number of pharmaceutical personnel
Density of pharmaceutical personnel (per 10 000 population)
Adults aged &#8805; 20 years who are obese (%)
Ambient air pollution attributable deaths
Ambient air pollution  attributable deaths per 100'000 children under 5 years
Total density per million population: Telecobalt Unit
Total density per million females aged from 50 to 69 years old: Mammography units
Number of cause-of-death registration years available
Presence of National Medicines Policy
Presence of National Medicines Policy implementation plan
Right of access to essential medicines
For the pharmaceutical sector
Annual consumption of Morphine (mg/capita)
National pharmacovigilance centre linked to the MRA exists
Number of reports submitted in the last two year by the pharmacovigilance centre
Children <5 years receive free medicines
Public sector
Private sector
Substitution of generic equivalents at the point of dispensing in public sector facilities is allowed
Substitution of generic equivalents at the point of dispensing in private sector facilities is allowed
Preterm birth rate (per 100 live births)
Health warnings on other smoked tobacco packaging must be rotated
Year of survey of youth
Representativeness of youth survey
Access to a toll-free quit line
Smoking cessation support is available in hospitals
Smoking cessation support is available in other settings
Nicotine replacement therapy - legally sold
Varenicline - legally sold
Varenicline - place available
Fines for violations
Fines on the establishment
Raised total cholesterol (&#8805; 6.2 mmol/L) (crude estimate)
Population
Age-standardized death rates, liver cancer, per 100,000
Age-standardized death rates, self-inflicted injury, per 100,000
Monitoring
Interventions, projects, training
Surveys, research
Specialized treatment services for drug use disoders and HIV/AIDS
Sector for outpatient treatment of drug dependence
Length of stay for inpatient long-term residential treatment, days
Sector for inpatient treatment of alcohol dependence
Beds for the treatment of substance use disorders, per 100 000
Sector for substitution maintenance therapy of opioid dependence
Government benefits for alcohol use disorders, subsidy or disability pension
Essential list of medicines
Age-standardized DALYs, drownings, per 100,000
Age-standardized DALYs, fires, per 100,000
Age-standardized DALYs, liver cirrhosis, per 100,000
Age-standardized DALYs, oesophagus cancer, per 100,000
Standards of care for health professionals
Health professionals mostly involved in treatment of substance use disorders
Supervision requirements for buprenorphine administration
Supervision requirements for methadone administration
Buprenorphine/naloxone used for the treatment of opioid dependence
Timeframe of opioid agonist treatment
Opioid agonist pharmacotherapy for the treatment of opioid dependence (detoxification or maintenance)
Buprenorphine used for the treatment of opioid dependence
Training in screening and brief interventions for alcohol problems
Designation of alcohol tax revenues to health services
Brief interventions as health promotion/disease prevention
Consumer information on alcohol and health at points of sale
Confirmed cases of MDR-TB started treatment for MDR-TB (%)
Government expenditures on mental health as a percentage of total government expenditures on health (%)
ICT Development Index (IDI) rank
Excise tax as a per cent of the total retail price for 1 litre of pure alcohol
Antenatal care attendees positive for syphilis who received treatment (%)
Mobile-cellular telephone subscriptions per 100 inhabitants
Total density per 100 000 population: Provincial hospitals
Preparedness
Risk communication
Laboratory
Number of reported cases of tuberculosis (DOTS)
UV radiation
UV radiation attributable deaths
UV radiation attributable deaths per 100'000 capita
UV radiation attributable DALYs ('000)
Distribution of years of life lost by broader causes (%) - Injuries
Total density per million population: Positron Emission tomography
International Statistical Classification of Diseases and Related Health Problems (ICD)
Number of national population surveys -  adult health
Registration Fee pharmaceutical containing New Chemical Entity
Registration Fee generic pharmaceutical product
Inspectors are allowed to inspect premises where pharmaceutical activities are performed
Pharmaceutical manufacturers must comply with Good Manufacturing Practices
Duties on imported active pharmaceutical ingredients
Duties on imported finished pharmaceutical products
Public sector tender awards are publicly available
National Essential Medicine List exists
Existence of a formal pre-hospital care system
Gross national income per capita (Atlas method)
Perceived trend in production
Confidentiality of health records on substance use disorders  protected by law
Legislative provision for compulsory treatment
Government unit for substance use disorder treatment
Sector for outpatient treatment of alcohol dependence
Sector for inpatient treatment of drug dependence
Age-standardized death rates, ischaemic heart disease, per 100,000
Age-standardized DALYs, falls, per 100,000
Age-standardized DALYs, ischaemic heart disease, per 100,000
Age-standardized DALYs, mouth and oropharynx cancer, per 100,000
Age-standardized DALYs, prematurity and low birth rate, per 100,000
Funding method for substance use disorder prevention
Screening and brief interventions for substance use and substance use disorders
National surveys on drink-driving
Population median age (years)
Gender inequality index rank
Community-based interventions involving stakeholders
National guidelines for implementing effective community-based interventions
Radionuclear
Food safety
Alcohol, total (recorded + unrecorded) per capita (15+) consumption, projected estimates for 2016
Alcohol, total  (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2025
Response
Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol)
Age-standardized DALYs (per 100,000)
Alcohol, tourist consumption (in litres of pure alcohol)
15-19 years old abstainers, lifetime (%)
15-19 years old former drinkers (%)
Civil registration coverage of cause-of-death (%)
Distribution of years of life lost by major cause group
National surveys on heavy espisodic drinking
Workplace representatives nationally involved to prevent and address alcohol-related harm
Legal obligation for schools to interact with parents regarding education and well-being
Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol)
Data collected on harm from alcohol at workplace
Clinical guidelines for brief interventions
Legal obligation for schools to include alcohol use prevention
Alcohol, patterns of drinking score
Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average
Most recent census (year)
Data collection on Foetal Alcohol Syndome
Comprehensive and regular reporting of alcohol situation
Regular reports from national monitoring systems
Number of deaths
15-19 years old total alcohol consumption in litres of pure alcohol
Gross national income per capita (PPP int. $)
Number of cases of visceral leishmaniasis reported
Prevalence of smoking any tobacco product among persons aged >= 15 years
General availability of cervical cytology at the primary health care level
General availability of peak flow measurement spirometry at the primary health care level
General availability of aspirin (100 mg) in the public health sector
General availability of steroid inhalers in the public health sector
Existence of population-based cancer registry
15-years old any alcoholic beverage consumed in past 30 days, (%)
Population using solid fuels (%)
Congenital syphilis number of reported cases
Existence of operational policy/strategy/action plan for chronic respiratory diseases
Compliance of ban on smoking in EDUCATIONAL FACILITIES EXCEPT UNIVERSITIES
Compliance of ban on smoking in UNIVERSITIES
Compliance of ban on smoking in INDOOR OFFICES
Compliance of ban on brand name of non-tobacco products used for tobacco product
Compliance of ban on non-tobacco goods AND services identified with tobacco brand names
Compliance of ban on appearance of tobacco brands in TV and/or films (product placement)
Compliance of ban on advertising on local magazines and newspapers
Compliance of ban on advertising on billboards and outdoor advertising
Compliance of ban on promotional discounts
Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
Appearance of tobacco products in TV and/or films
Status of bejel endemicity
Number of cases of cutaneous leishmaniasis reported
Civil registration coverage of births (%)
Antenatal care coverage - at least one visit (%)
Total density per 100 000 population: Hospitals
Contraceptive prevalence (%)
General availability of colon cancer screening at the primary health care level
General availability of total cholesterol measurement at the primary health care level
General availability of urine testing for albumin
General availability of bronchodilators in the public health sector
General availability of metformin in the public health sector
General availability of statins in the public health sector
Congenital syphilis rate per 100 000 live births
Existence of operational policy/strategy/action plan to decrease tobacco use
Existence of operational policy/strategy/action plan to reduce physical inactivity
Stand-alone policy or plan for mental health
Compliance of ban on smoking in HEALTH-CARE FACILITIES
Compliance of ban on smoking in RESTAURANTS
Compliance with bans on promotion and sponsorship
Compliance with bans on direct advertising
Ban on tobacco companies/tobacco industry publicizing their “Corporate Social Responsibility” activities
Required anti-tobacco ads for any visual entertainment media product that depicts tobacco products, use or images
Compliance with regulations on smoke-free environments (national legislation)
Ban on entities other than tobacco companies/tobacco industry publicizing the Corporate Social Responsibility� activities of the tobacco companies
Complete ban on tobacco vending machines
Sponsored events
Ban on display of tobacco products at points of sale
Subnational bans on tobacco advertising, promotion and sponsorship
Adult survey age range
Tax administration: Bans or limits on duty free imports by travellers
Tax administration: Tax stamps applied on tobacco products
Youth smokeless tobacco use indicator definition
Subnational advertising, promotion and sponsorship bans - at least one jurisdiction has a comprehensive ban in place
Compliance of ban on smoking in PUBS AND BARS
Compliance of ban on smoking in PUBLIC TRANSPORT
Compliance of ban on smoking in GOVERNMENT FACILITIES
Compliance of ban on sponsored events
Compliance of ban on free distribution of tobacco products in the mail or through other means
Compliance of ban on advertising on national TV and radio
Compliance of ban on appearance of tobacco products in TV and/or films
Compliance of ban on advertising at point of sale
Comprehensive bans in place subnationally
Tobacco excises increased over the survey period
Adult indicator 2 rate
Youth smokeless tobacco use indicator rate
Status of pinta endemicity
General availability of insulin in the public health sector
General availability of nicotine replacement therapy in the public health sector
General availability of oral morphine in the public health sector
Existence of operational policy/strategy/action plan for cancer
Existence of operational policy/strategy/action plan to reduce the harmful use of alcohol
Existence of operational policy/strategy/action plan to reduce unhealthy diet related to NCDs
Stand-alone law for mental health
Ban on advertising: Point of sale
Law requires fines for violations of direct advertising bans
Law requires fines for violations of indirect advertising bans
Youth indicator 1 definition
Adult indicator 1 rate
Adult smokeless tobacco use indicator rate
Average - taxes as a % of cigarette price - specific excise
Average - taxes as a % of cigarette price - other taxes
Average - taxes as a % of cigarette price - import duties
Average - taxes as a % of cigarette price - total tax
Prevalence of tuberculosis (per 100 000 population)
Number of prevalent tuberculosis cases
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%)
Laboratories providing drug susceptibility testing (DST) (per 5 million population)
Laboratories providing tuberculosis diagnostic services using sputum smear microscopy (per 100 000 population)
Laboratories providing tuberculosis diagnostic services using culture (per 5 million population)
Total number of notified TB cases
General availability of breast cancer screening (by palpation or mammogram) at the primary health care level
General availability of diabetes testing (by blood glucose measurement, OGTT, or HbA1c) at the primary health care level
General availability of ACE inhibitors in the public health sector
General availability of CC blockers in the public health sector
General availability of thiazide diuretics in the public health sector
Existence of an Operational Unit, Branch, or Dept. in Ministry of Health with responsibility for NCDs
Existence of an NCD surveillance and monitoring system in place to enable reporting against the nine global NCD targets
Existence of operational policy/strategy/action plan for cardiovascular diseases
Existence of operational policy/strategy/action plan for diabetes
Adult indicator 1 definition
Name of survey of youth
Name of survey of adults
Affordability: Cigarettes are less affordable in 2014 compared to 2008
Adult smokeless tobacco use indicator definition
Process evaluation was employed to assess implementation
Youth indicator 1 rate
Average - taxes as a % of cigarette price - value added tax
Average - taxes as a % of cigarette price - ad valorem excise
Second-line drug susceptibility testing (DST) available
Age-standardized deaths attributable to the environment (per 100 000 population)
Deaths attributable to the environment
Private prepaid plans as a percentage of private expenditure on health
Per capita government expenditure on health at average exchange rate (US$)
Per capita total expenditure on health (PPP int. $)
Per capita government expenditure on health (PPP int. $)
General government expenditure on health as a percentage of total government expenditure
External resources for health as a percentage of total expenditure on health
Social security expenditure on health as a percentage of general government expenditure on health
Out-of-pocket expenditure as a percentage of private expenditure on health
Total expenditure on health as a percentage of gross domestic product
Private expenditure on health as a percentage of total expenditure on health
General government expenditure on health as a percentage of total expenditure on health
Per capita total expenditure on health at average exchange rate (US$)
Reported number of human rabies deaths
Out-of-pocket expenditure as a percentage of total expenditure on health
Existence of a set of national NCD indicators and has set time-bound national targets for these indicators
Existence of any policies on marketing of foods to children
Population living in urban areas (%)
General availability of diabetes testing (by blood glucose measurement, OGTT) at the primary health care level
Existence of national screening program for breast cancer
Type of national cervical cancer screening program
General availability of dialysis in the public health system
General availability of renal replacement by transplantation in the public health system
General availability of coronary bypass or stenting in the public health system
General availability of thrombolytic therapy in the public health system
General availability of palliative care in primary health care in the public health system
General availability of palliative care in community or home-based care in the public health system
General availability of sulphonylurea(s) in the public health sector
DALYs attributable to ambient air pollution (age-standardized)
Number of imported cases of cutaneous leishmaniasis reported
Raised blood pressure (SBP>=140 OR DBP>=90) (age-standardized estimate)
Raised blood pressure (SBP>=140 OR DBP>=90) (crude estimate)
Mean systolic blood pressure (age-standardized estimate)
Number of licensed qualified anaesthesiologists actively working
Countries that have passed legislation on Universal Health Coverage (UHC)
Ministry/office that takes primary responsibility for prevention for substance use
Ministry/office that takes primary responsibility for treatment of substance use disorders
Involvement of representatives of affected or targeted populations in the development and implementation of national programmes for treatment of substance use disorders
Involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for prevention for alcohol and drugs
Compulsory treatment for people with alcohol use disorders in the criminal justice system
Compulsory treatment for people with drug use disorders in the criminal justice system
Five-year change in government resources for treatment of substance use disorders
Financing methods for treatment for alcohol use disorders
Financing methods for treatment for drug use disorders
Government benefits for people with alcohol use disorders
Government benefits for people with drug use disorders
Main substance at treatment entry
Pharmacotherapy with methadone
Pharmacotherapy with buprenorphine/naloxone
Registration of medications for alcohol dependence and withdrawal
Registration of medications for opioid dependence
Recommendations for screening and brief interventions for substance use in antenatal services
Groups and agencies involved in prevention programs
Prevention programmes for specific populations for alcohol
Ambient air pollution attributable DALYs
Prevention programmes for drugs
HIV, Hepatitis counselling and treatment availability in specialized facilities and services
Programmes readily available
Special treatment programmes for gambling disorder
Treatment programmes for women with alcohol use disorders
Special housing services for alcohol use disorders
Special housing services for drug use disorders
Open access interventions for drugs
Health professionals providing treatment for alcohol and drug use disorders
Postgraduate training programme in prevention
Continuing professional development in prevention
Educational attainment in treatment
Postgraduate training programme in treatment
Service delivery data collection for substance use
Regular reports on epidemiological and service delivery data for substance use
Treatment programmes for children and adolescents with alcohol use disorders
Standards of care for professionals providing treatment for alcohol and drug use disorders
Access restrictions to maintenance treatment
Prevention programmes for specific populations for drugs
Self-help groups
Prevalence of obesity among adults, BMI &GreaterEqual; 30 (age-standardized estimate) (%)
Prevalence of obesity among adults, BMI &GreaterEqual; 30 (crude estimate) (%)
Prevalence of underweight among adults, BMI < 18.5 (age-standardized estimate) (%)
Tax structure: Excise tax proportion of price
Youth survey age range
Adult indicator 2 definition
Representativeness of survey of adults
Disability-adjusted life years (DALYs) attributable to the environment
Age-standardized DALYs attributable to the environment (per 100 000 population)
Disability-adjusted life years (DALYs) attributable to the environment (%)
Existence of an operational, multisectoral national NCD policy, strategy or action plan that integrates several NCDs and their risk factors
Existence of any policies to reduce population salt consumption
Implementation of diet and/or physical activity public awareness program
General availability of diabetes testing (by HbA1c) at the primary health care level
Availability of cardiovascular risk stratification in 50% or more primary health care facilities
Provision for care of acute stroke and rehabilitation in more than 50% of public sector health facilities
Number of imported cases of visceral leishmaniasis reported
Number of licensed qualified obstetricians actively working
Government unit/official responsible for treatment of substance use disorders
Involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for treatment of substance use disorders
Involvement of representatives of affected or targeted populations in the development and implementation of national programmes for prevention for alcohol and drugs
Confidentiality of people in treatment for substance use disorders
Voluntary treatment for people with alcohol use disorders in the criminal justice system
Five-year change in government resources for prevention for substance use
Main sector for treatment for drug use disorders
Treatment programmes for children and adolescents with drug use disorders
Specialized treatment facilities for alcohol use disorders
Guidelines on pharmacological treatment for substance use disorders
Pharmacotherapy with buprenorphine
Registration of medications for opioid withdrawal
Adolescent mortality rate (per 100 000 population)
Screening and brief intervention for substance use in antenatal services
Recommendations for screening and brief interventions for substance use in primary health care
Prevention programmes for alcohol
Employment services for alcohol use disorders
Open access interventions for alcohol
Educational attainment in prevention
Continuing professional development in treatment
System of monitoring drugs involvement in forensic pathology
Epidemiological data collection system for substance use among children and adolescents
Five years change in international cooperation for prevention for substance use
Voluntary treatment for people with drug use disorders in the criminal justice system
Specialized treatment facilities for drug use disorders
Prevalence of underweight among adults, BMI < 18.5 (crude estimate) (%)
Tax administration: If duty free imports are limited, duty free allowance (number of cigarette sticks)
Estimated MDR-TB cases among notified pulmonary TB cases
Existence of a national multisectoral commission, agency or mechanism for NCDs
Has a STEPS survey or a comprehensive health examination survey every 5 years
Existence of national screening program for cervical cancer
General availability of retinal photocoagulation in the public health system
Provision for secondary prevention of rheumatic fever and rheumatic heart disease in more than 50% of public sector health facilities
General availability of beta blockers in the public health sector
Coverage of national cervical cancer screening program (%)
Number of personal care workers
Number of licensed qualified surgeons actively working
Five years change in international cooperation for treatment of substance use disorders
Screening and brief intervention for substance use in primary health care
Standards of treatment and care for public specialized treatment facilities
Employment services for drug use disorders
Epidemiological data collection for substance use
System of monitoring alcohol involvement in forensic pathology
Hypothecated taxes to be spent on prevention and treatment for substance use disorders
Specialized treatment facilities for substance use disorders
Availability of naloxone
Treatment programmes for women with drug use disorders
Mean BMI (kg/m&#xb2;) (age-standardized estimate)
Deaths attributable to the environment (%)
Existence of a diabetes registry
Most widely used screening method in national cervical cancer screening program
Existence of national HPV vaccination programme
Government unit/official responsible for prevention for substance use
Timeframe for maintenance treatment of opioid dependence
Registration of naloxone for injection for opioid overdose
Ambient air pollution attributable deaths (per 100 000 population, age-standardized)
Prevalence of overweight among adults, BMI &GreaterEqual; 25 (age-standardized estimate) (%)
Prevalence of overweight among adults, BMI &GreaterEqual; 25 (crude estimate) (%)
Prevalence of overweight among children and adolescents, BMI > +1 standard deviations above the median (crude estimate) (%)
Prevalence of obesity among children and adolescents, BMI > +2 standard deviations above the median (crude estimate) (%)
Prevalence of thinness among children and adolescents, BMI < -2 standard deviations below the median (crude estimate) (%)
Raised fasting blood glucose (>= 7.0 mmol/L or on medication) (crude estimate)
Raised fasting blood glucose (>=7.0 mmol/L or on medication)(age-standardized estimate)
Sex workers with active syphilis (%)
Number of nursing personnel
Number of pharmacists
Number of dentists
Physicians density (per 1000 population)
Dentistry personnel density (per 1000 population)
Pharmaceutical personnel density (per 1000 population)
Reported treatment coverage for substance dependence
Population (in thousands) total
Population proportion under 15 (%)
Population proportion over 60 (%)
National eHealth strategy
Public funding for eHealth
Providing incentives and guidance for innovation research and evaluation of health
Lack of capacity
Enabling access to education where learning facilities are limited
Improving access to content and experts
Lack of infrastructure
eLearning used for in-service training of health professionals
Competing health system priorities
Lack of demand by health professionals and patients
to address patient safety and quality of care based on data quality, data transmission standards, or clinical competency criteria
Privacy and security laws need to be in place
Effective standards and best practices for data capture not fully established
Births by caesarean section (%)
Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol)
Adult mortality rate (probability of dying between 15 and 60 years per 1000 population)
Existence of a set of time-bound national targets based on WHO guidance
Existence of operational policy/strategy/action plan for oral health
Implementation of physical activity public awareness program
Average of 13 International Health Regulations core capacity scores, 1st version of the questionnaire
Compliance with international health regulations
Number of physicians
Number of midwifery personnel
Nursing and midwifery personnel density (per 1000 population)
Total fertility rate (per woman)
Donor/ non-public development funding for eHealth
Proportion ofpublic private partnerships funding
Proportion of donor/non public development funding
Public-private partnerships for eHealth
strategy refers to the use of ICT to support UHC
National universal health coverage strategy
Capacity
Policy
Infrastructure
Effectiveness
Providing guidance on privacy and security
Promoting the development and adoption of mHealth
Funding
Demand
Country has telehealth policy or strategy
eLearning courses accredited by continuing medical education or professional licensing bodies
Lack of evidence over cost-effectiveness
Reducing cost of delivering content
lack of evidence showing effectiveness of EHR
Country has national EHR
Lack of funding
to protect the privacy of individuals' health-related  data held in electronic format as an EHR
to protect privacy of personally identifiable data of individuals irrespective of whether it is paper or digital format
which governs the sharing of digital data between health professionals  in health services in other countries through the use of an EHR
Capacity building required for new skills
Country has national policy or strategy regulating the use of big data by private companies
Estimated direct deaths from major conflicts (per 100 000 population)
Has systems for follow-up/recall to deliver long-term penicillin prophylaxis to patients with rheumatic fever and rheumatic heart disease
Ambient and household air pollution attributable death rate (per 100 000 population)
Ambient and household air pollution attributable death rate (per 100 000 population, age-standardized)
Men who have sex with men (MSM) with active syphilis (%)
Estimated population-based prevalence of depression
Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%)
Tertiary institutions provide students of health sciences with training on eHealth
Proportion of public funding
National  health information system (HIS) policy or strategy
Institutions offer in-service training to health professionals on ICT for health
Government-supported health internet sites provide information in multiple languages
mHealth programmes are sponsored by government
Cost-effectiveness
Evaluation of any government-sponsored telehealth programmes
eLearning programmes for in-service training of health professionals have been evaluated
Lack of evidence that eLearning is effective
Lack of demand for eLearning programmes
Not possible to gain a health sciences degree entirely through eLearning
Country has specific legislation governing the use of national EHR system
Country has national policy or strategy on the use of social media by government organizations
which allows individuals electronic access to their own health-related data when held in an EHR
Individuals have the legal right to specify which health-related data from their EHR can be shared with health professionals of their choice
to define medical jurisdiction, liability or reimbursement of eHealth services such as telehealth
which allows individuals to demand the deletion of health-related data from their EHR
Insufficient incentives for data sharing
Ill-defined causes in cause-of-death registration (%)
Existence of evidence-based national guidelines/protocols/standards for the management of major NCDs through a primary care approach
Concentrations of fine particulate matter (PM2.5)
Legislative status
Household air pollution attributable deaths
Skilled health professionals density (per 10 000 population)
Strategy implementation funding available for eHealth
Private funding for eHealth
Proportion of private funding
National eHealth strategy refers to objectives of UHC
Providing oversight and enforcement of data ownership
Regulating mobile devices and software
Legal
Government-sponsored mHealth programmes are being evaluated
Promoting standards and interoperability
Regulatory oversight of mobile apps for quality, safety and reliability
Priorities
Strategy includes objectives as to how telehealth contributes to UHC
Insitutional educational policy does not include eLearning as an approach to teaching health sciences
Competing educational priorities
Lack of suitable courses available
Pre-service eLearning programmes have been evaluated
eLearning is used in pre-service education to teach health sciences students
National strategy does not promote the adoption of EHR
Lack of legislation or regulations covering use of EHR
Lack of evidence showing cost-effectiveness or EHR
Lack of national or international standards for interoperability of EHR
Policy or strategy makes specific reference tothe use of social media in the health domain
which allows for the sharing of personal and health data between research entities
which governs the sharing of digital data between health professionals in other health services in the same country through the use of an EHR
which allows individuals to demand that their own data be corrected  when held in an EHR if it is known to be inaccurate
Research into new analytical methods needs occur to meet the challenges of working with big data
Lack of integration between various health services
Country has  national policy or strategy regulating the use of big data in the health sector
Existence of a register of patients who had rheumatic fever and rheumatic heart disease
Household air pollution attributable death rate (per 100 000 population)
Household air pollution attributable death rate (per 100 000 population, age-standardized)
Household air pollution attributable DALYs
Household air pollution attributable DALYs (per 100 000 population)
Household air pollution attributable DALYs (per 100 000, age-standardized)
Ambient air pollution attributable deaths in children under 5 years
Ambient air pollution attributable death rate (per 100 000 population, age-standardized)
Ambient air pollution attributable death rate (per 100 000 population)
Ambient air pollution attributable DALYs  (per 100 000 population)
Ambient air pollution attributable DALYs  (per 100 000 population, age-standardized)
SDG 3.9.2 WASH deaths
Number of diarrhoea deaths from inadequate hygiene
Number of diarrhoea DALYs from inadequate water, sanitation and hygiene
Ambient air pollution attributable YLLs
Alcohol, total  (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2020 and 2025
Alcohol, abstainers lifetime (%)
Biomedical technicians density (per 10 000 population)
Alcohol, former drinkers (%)
Alcohol, consumers past 12 months (%)
Alcohol-related road traffic crashes, per 100,000 population
Alcohol, harmful use (15+), 12 month prevalence (%) with 95%CI
Advertising restrictions on local radio
Advertising restrictions on national radio
Advertising restrictions on cable television
National legislation to prevent illegal alcohol
Advertising restrictions on the internet
Advertising restrictions on social media
Advertising restrictions at cinemas
Advertising restrictions at point-of-sale
Restrictions on product placement in films/movies
Restrictions on product placement on cable television
Government support for community action
Penalties for drink driving
Penalties for marketing infringements
Price measures
Off-premise sales restrictions on outlet density
Off-premise sales restrictions at specific events
Off-premise sales restrictions on places
On-premise sales restrictions on days
On-premise sales restrictions on hours
On-premise sales restrictions on outlet density
On-premise sales restrictions on places
Restrictions on sales promotion from retailers (sales below cost)
On-premise sales restrictions to intoxicated persons
Restrictions on sales promotion from owners of pubs and bars (alcohol for free)
Monopoly on exports of alcoholic beverages
Licensing required for exports of alcoholic beverages
Monopoly on imports of alcoholic beverages
Government monopoly on retail sales
Excise tax on alcoholic beverages
Level of taxation adjusted for inflation
Tax incentives for production low/no alcohol content beer
Value-added tax (VAT) on alcohol (%)
Alcohol content displayed on containers
Health warning labels on under-age drinking
Number of standard alcoholic drinks displayed on containers
Consumer information about calories, additives, etc on containers
Licence required for production
Alcohol use disorders (15+), 12 month prevalence (%) with 95%
Awareness activities
National guidelines for alcohol problem prevention and counselling at workplaces
Standard drink defined
National surveys on adult alcohol consumption
Report with data from health services on alcohol use and AUDs
15-19 years old heavy episodic drinkers (population), % with 95%CI
15-19 years old heavy episodic drinkers (drinkers only), %
Heavy episodic drinking (youth 15 -19 years) past 30 days (%)
Cancer, age-standardized death rates (15+), per 100,000 population
Alcohol-attributable fractions (15+), liver cirrhosis deaths (%)
Road traffic injuries, age-standardized death rates (15+), per 100,000 population
Alcohol-attributable fractions (15+), road traffic crash deaths (%)
Liver cirrhosis, age-standardized death rates (15+), per 100,000 population
Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%)
Age limits on-premise service
Alcohol, consumption of pure alcohol by type of beverage (%)
National legislation to prevent illegal alcohol sales
National drinking guidelines
Penalties for drink driving, repeated offense
Graduated licensing
Alcohol dependence (15+ ), 12-month prevalence (%) with 95%CI
Government monopoly on production
Excise duty (average) per hectolitre in Euros
Restrictions on alcohol use in public places
Age limits off-premise sales
Alcohol, average daily intake in grams among drinkers with 95%CI
Alcohol use disorders (15+), 12 month prevalence (%), age standardized, with 95%CI
Legislation on alcohol testing at workplaces
Annual revenues from alcohol excise tax in millions US$
15-years old any alcoholic beverage consumed in past 12 months, (%)
15-years old first drink at 13 years or younger, (%)
15-years old, any alcoholic beverage consumed at least once a week, (%)
Off-premise sales restrictions on days
On-premise sales restrictions at specific events
Legal blood alcohol concentration (BAC) limits
Heavy episodic drinking (youth 15 -19 years), drinkers only, past 30 days (%)
Average price 750 mls Wine in US$
Deaths per 1 000 live births
Distribution of causes of death among children aged < 5 years (%)
Main sector for treatment for alcohol use disorders
Household air pollution attributable DALYs in children under 5 years
Ambient air pollution attributable DALYs  in children under 5 years
Number of diarrhoea DALYs from inadequate hygiene
Number of diarrhoea deaths from inadequate water, sanitation and hygiene
Attributable fraction of diarrhoea to inadequate water, sanitation and hygiene
Alcohol, drinkers only per capita (15+)consumption in litres of pure alcohol
Existence of tax on sugar-sweetened beverages
Number of biomedical technicians
Biomedical engineers density (per 10 000 population)
Alcoholic beverage legally defined
Advertising restrictions on national television
Advertising restrictions on billboards
Advertising restrictions in print media
Sobriety checkpoints
Detection of marketing infringements
Off-premise sales restrictions on hours
Restrictions on sponsorship of youth events
Restrictions on sales promotion from producers (parties, events)
Restrictions on sponsorship of sporting events
Licensing required for wholesale/distribution of alcoholic beverages
Licensing required for imports of alcoholic beverages
Monopoly on wholesale /distribution of alcoholic beverages
Licenses issued for wholesale/distribution, change since 2010
Licenses issued for retail sale, change since 2010
Tax incentives for production of other alcoholic beverages
Duty paid or excise stamp on alcohol container
Taxation of ethanol production
Health warning labels on pregnancy
Licence required for retail sales
National systems for monitoring alcohol consumption and harms
National system of epidemiological data collection for alcohol use
Alcohol-attributable fractions (15+), cancer deaths
Prevalence of insufficient physical activity among adults aged 18+ years (crude estimate) (%)
Alcohol, heavy episodic drinking (population) past 30 days (%)
Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average with 95%CI
15-19 years old, current drinkers (%)
Off-premise sales restrictions at petrol stations
Attributable fraction of diarrhoea to inadequate hygiene
Adopted written national policy on alcohol
Restrictions on product placement on national television
Level of enforcement of BAC limits
Health warning labels on alcohol containers
Health warning labels on alcohol advertising
Licenses issued for production, change since 2010
Ethanol tax deducted from excise tax
National guidelines for the prevention and reduction of alcohol-related harm in schools
National surveys on youth alcohol consumption
Report with epidemiological data on lcohol use and AUDs
National organization for monitoring alcohol
Alcohol-attributable Years of Life Lost (YLL) score
Alcohol-attributable fractions, all-cause deaths (%)
Alcohol, abstainers past 12 months (%)
Alcohol, heavy episodic drinking (15+), drinkers only, past 30 days (%)
Average price 500 mls Spirits in US$
Household air pollution attributable deaths in children under 5 years
Number of biomedical engineers
Random breath testing (RBT) use
Health warning labels on drink-driving
Legal requirement for size of health warning labels
Server training
National system of data collection based on health service delivery
Alcohol, heavy episodic drinking (15+) past 30 days (%), age-standardized with 95%CI
Average price 500 mls Beer in US$
Leprosy - Number of cases registered for treatment
Leprosy - Number of new child (less than 15 years of age) cases
Leprosy - Number of new child (less than 15 years of age) cases detected with G2D
Practice of backyard pig production
Leprosy - Number of new G2D cases
Leprosy - Number of female new cases
Number of pigs in the country
Leprosy - New cases detection rate per 100 000 population
Leprosy - Registered cases per 10 000 population
Completeness of cause-of-death data (%)
Participation rate in organized learning (one year before the official primary entry age) (%)
Proportion of children at the end of lower secondary achieving at least a minimum proficiency level in mathematics (%)
Low birth weight, prevalence (%)
Low birth weight (in thousands)
Population using safely managed drinking-water services (%)
Population using at least basic drinking-water services (%)
Population using safely managed sanitation services (%)
Population using at least basic sanitation services (%)
Population practising open defecation (%)
Proportion of ever-partnered women and girls aged 15-49 years subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months
Data availability for UHC index of service coverage
Poliomyelitis - number of reported cases
Number of maternal deaths
Maternal mortality ratio (per 100 000 live births)
Number of new leprosy cases
Prevalence of insufficient physical activity among school going adolescents aged 11-17 (crude estimate)
Population pushed below the $1.90 a day poverty line by household health expenditures (%)
Increase in poverty gap due to household health expenditures, expressed as a proportion of the $1.90 a day poverty line (%)
Increase in poverty gap due to household health expenditures at the $3.20 a day poverty line, in cents of international dollars
Population pushed below a relative poverty line by household health expenditures (60% of median daily per capita consumption or income) (%)
Increase in poverty gap due to household health expenditures, expressed as a proportion of a relative poverty line (60% of median daily per capita consumption or income) (%)
Reporting countries
Proportion of isolates with resistance to azithromycin reported to WHO-GASP
Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP
Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP
Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP
Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP
Number of isolates tested for azithromycin
Number of isolates tested for cefixime
Number of isolates tested for ceftriaxone
Number of isolates tested for extended-spectrum cephalosporins
General availability of Angiotensin II receptor blockers (ARBs) in the public health sector
Prevalence of current tobacco use among persons aged 15 years and older (age-standardized rate)
Distribution of road traffic deaths by type of road user (%)
Persistence to last grade of primary (% of cohort)
Alcohol, total per capita (15+) consumption (in litres of pure alcohol) with 95%CI
Availability of estimates on large health expenditures as a share of total expenditure or income
Presence of porcine cysticercosis
Leprosy - New leprosy cases with G2D rate per 1 000 000 population
Average death rate due to natural disasters (per 100 000 population)
Proportion of population below the international poverty line of US$1.90 per day (%)
UHC SCI components:  Infectious diseases
UHC SCI components: Service capacity and access
Population with household expenditures on health greater than 10% of total household expenditure or income (SDG indicator 3.8.2) (%)
Population with household expenditures on health greater than 25% of total household expenditure or income (SDG indicator 3.8.2) (%)
Increase in poverty gap due to household health expenditures at the $1.90 a day poverty line, in cents of international dollars
Increase in poverty gap due to household health expenditures, expressed as a proportion of the $3.20 a day poverty line (%)
Number of isolates tested for ciprofloxacin
Estimated number of tests performed where results were received by a person (testing volume), estimated number per 1000 population
Formative research was conducted prior to the campaign
Outcome evaluation was employed to assess effectiveness of the campaign
Campaign was part of a comprehensive tobacco control programme
Campaign was pre-tested
Process evaluation was employed to assess implementation of the campaign
Campaign utilized media planning
At least one national mass media campaign ran during the survey period
Earned media/public relations were used to promote the campaign
Campaign ran on both national television and radio
Compliance with ban on use of brand name of non-tobacco product for tobacco product (score)
Compliance with ban on billboard and outdoor advertising (score)
Subnational bans on advertising, promotion and sponsorship - at least one jurisdiction has a comprehensive ban in place
Enforce bans on tobacco advertising
Ban on advertising on national television and radio
Ban on promotional discounts
Ban on identifying non-tobacco products with tobacco brand names
Ban on use of brand name of non-tobacco product for tobacco product
Ban on appearance of tobacco brands in TV and/or films (product placement)
Ban on appearance of tobacco products in TV and/or films
Ban on sponsorship (contributions and/or publicity of contributions)
Ban on any form of contribution (financial or other support) to any event, activity or individual
Banning the publicity of financial or other sponsorship or support by the tobacco industry of events, activities, individuals
Ban on Corporate Social Responsibility activities (CSR)
Ban on tobacco companies/the tobacco industry publicizing their CSR activities
Ban on entities other than tobacco companies/the tobacco industry publicizing the CSR activities of the tobacco companies/industry
Ban on tobacco companies funding or making contributions (including in-kind contributions) to smoking prevention media campaigns, including those directed at youth
Ban on advertising on international television and radio
Law requires fines for violations of advertising bans
Law requires fines for violations of promotion and sponsorship bans
Subnational bans on tobacco advertising, promotion and sponsorship authority exists
Ban on tobacco vending machines
Ban on internet sales of tobacco products
Ban on billboard and outdoor advertising
Ban on advertising at point of sale
Ban on product display at point of sale
Ban on advertising on the internet
Ban on free distribution in mail or through other means
Mortality rate attributed to exposure to unsafe WASH services (per 100 000 population) (SDG 3.9.2)
Proportion of children in grades 2/3 achieving at least a minimum proficiency level in mathematics (%)
Proportion of children at the end of lower secondary achieving at least a minimum proficiency level in reading (%)
Average of 13 International Health Regulations core capacity scores, SPAR version
UHC SCI components: Noncommunicable diseases
Data availability for UHC index of service coverage (ranking)
Population pushed below the $3.20 a day poverty line by household health expenditures (%)
Reported number of tests performed where results were received by a person (testing volume), reporting period
Existence of national policies on saturated fatty acids
Existence of national policies on trans-fatty acid elimination
Compliance with ban on advertising on national television and radio (score)
Compliance with ban on indentifying non-tobacco products with tobacco brand names (score)
Compliance with ban on sponsorship (contributions and/or publicity of contributions) (score)
Compliance with ban on advertising at point of sale (score)
Ban on advertising in international magazines and newspapers
Monitor
National agency for tobacco control exists
Number of full-time equivalent staff in national agency
Cytisine - legally sold
Cytisine - place available
Smoking cessation support is cost-covered in the community
Smoking cessation support is cost-covered in health clinics or other primary care facilities
Smoking cessation support is cost-covered in offices of health professionals
Smoking cessation support is cost-covered in other settings
Nicotine replacement therapy - cost covered
Varenicline - cost covered
Compliance with smoke-free health-care facilities law (score)
Compliance with smoke-free government facilities law (score)
Compliance with smoke-free pubs and bars law (score)
Protect from tobacco smoke
Smoke-free health-care facilities (national legislation)
Fines for violations of smoke-free laws
Fines on the establishment for violations of smoke-free laws
Citizen complaints and investigations of violations of smoke-free laws
Smoke-free government facilities (national legislation)
Smoke-free pubs, bars and cafés (national legislation)
Smoke-free public transport (national legislation)
Most sold brand of cigarettes - taxes as a % of price - ad valorem excise
Tax stamps, fiscal marks, banderole or other types of marking are applied on cigarettes
Minimum specific tax applied in ad valorem or mixed excise regime
Type of excise tax applied.
Raise taxes on tobacco
Most sold brand of cigarettes - taxes as a % of price - other taxes
Most sold brand of cigarettes - taxes as a % of price - specific excise
Most sold brand of cigarettes - taxes as a % of price - value added tax
Tobacco tax revenues - total excise (specific and ad valorem)
Tobacco tax revenues - tobacco product types included
Law mandates that health warnings appear on cigarette packages
Health warnings on cigarette packaging must include a photograph or graphic
Health warnings appear on each cigarette package and any outside packaging and labelling used in the retail sale
Health warnings on cigarette packaging law applys to products whether manufactured domestically imported AND for duty-free sale
Health warnings on cigarette packaging do not remove or diminish the liability of the tobacco industry
Percentage of principal display area mandated to be covered by health warnings - back of cigarette packaging
Health warnings on cigarette packaging must be placed at the top of the principal display areas of the package
Font style, font size and colour of health warnings are mandated for cigarette packaging
Health warnings on cigarette packaging must be rotated
Health warnings on cigarette packaging must be written in the principal language(s) of the country
Health warnings on cigarette packaging must not be obscured in any way including by required markings such as tax stamps
Anti-tobacco mass media campaigns
Year of most recent survey of adults
Prevalence of current tobacco smoking among adolescents (%)
Prevalence of daily tobacco smoking among adolescents (%)
Availability of estimates on impoverishment due to out-of-pocket health expenditures
Status of endemicity of Taenia solium
Infants exclusively breastfed for the first six months of life (%)
UHC SCI components: Reproductive, maternal, newborn and child health
Reported number of tests performed where results were received by a person (testing volume)
Number of registered vehicles
General availability of bone marrow transplantation in the public health system
Overall compliance with bans on promotion and sponsorship (score)
Compliance with ban on appearance of tobacco products in TV and/or films (score)
Ban on advertising in local magazines and newspapers
Budget year
Annual budget for tobacco control in currency reported
Government objectives on tobacco control exist
Bupropion - cost covered
Cytisine - cost covered
Offer help to quit tobacco use
Smoking cessation support is cost-covered in hospitals
Nicotine replacement therapy - on the Essential Medicines List
Compliance with smoke-free education facilities except universities law (score)
Compliance with smoke-free public transport law (score)
Number of places smoke-free (national legislation)
Subnational smoke-free legislation authority exists
Fines on the patrons of establishments for violations of smoke-free laws
Dedicated funds for enforcement of smoke-free laws
Overall compliance with bans on direct advertising (score)
Compliance with ban on promotional discounts (score)
Compliance with ban on appearance of tobacco brands in TV and/or films (score)
Compliance with ban on advertising in local magazines and newspapers (score)
Compliance with ban on free distribution in mail or through other means (score)
National tobacco control budget - currency reported
Overall compliance with regulations on smoke-free environments (score)
Compliance with smoke-free universities law (score)
Compliance with smoke-free restaurants law (score)
Subnational smoking bans - at least one jurisdiction has a comprehensive ban in place
Smoke-free education facilities except universities (national legislation)
Smoke-free universities (national legislation)
Smoke-free indoor offices (national legislation)
Smoke-free restaurants (national legislation)
Smoke-free other indoor public places (national legislation)
Tax stamps, fiscal marks, banderole or other types of marking are applied on other tobacco products
Affordability - percentage of GDP per capita required to purchase 2000 cigarettes of the most sold brand
Price dispersion: Share of cheapest brand price in premium brand price (%) (the higher the % the smaller the gap)
Most sold brand of cigarettes - taxes as a % of price - import duties
Most sold brand of cigarettes - taxes as a % of price - total tax
Tobacco tax revenues - currency reported
Tobacco tax revenues - import duties and all other taxes
Tobacco tax revenues - year reported
Warn about the dangers of tobacco
Health warnings on cigarette packaging describe the harmful effects of tobacco use on health
Specific health warnings are mandated for cigarette packaging
Number of health warnings approved by the law for cigarette packaging
Health warnings on cigarette packaging law requires or establishes fines for violations
Ban on deceitful terms on cigarette packaging
Cigarette packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
Percentage of principal display area mandated to be covered by health warnings - front and back of cigarette packaging
Cigarette packaging and labelling must not use descriptors depicting flavours
Cigarette packaging and labelling must display qualitative information on emission yields
Emission yields must be displayed on one or more principle display areas of cigarette packaging
Display of expiry dates is prevented on cigarette packaging
The quit line number must appear on cigarette packaging or labelling
Plain packaging of cigarettes is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited)
Representativeness of most recent adolescent survey
Name of latest youth prevalence survey (nonsmoked)
Age range of latest youth prevalence survey (nonsmoked)
Prevalence of current tobacco use among adolescents (%)
Prevalence of daily tobacco use among adolescents (%)
Prevalence of current cigarette smoking among adolescents (%)
Prevalence of daily cigarette smoking among adolescents (%)
Prevalence of current smokeless tobacco use among adolescents (%)
Prevalence of daily smokeless tobacco use among adolescents (%)
Prevalence of current e-cigarette use among adolescents (%)
Prevalence of daily e-cigarette use among adolescents (%)
Prevalence of current tobacco use among adults (%)
Prevalence of daily tobacco use among adults (%)
Prevalence of current tobacco smoking among adults (%)
Prevalence of daily tobacco smoking among adults (%)
Prevalence of current cigarette smoking among adults (%)
Prevalence of daily cigarette smoking among adults (%)
Prevalence of current smokeless tobacco use among adults (%)
Prevalence of daily smokeless tobacco use among adults (%)
Prevalence of current e-cigarette use among adults (%)
Prevalence of daily e-cigarette use among adults (%)
Mean fasting blood glucose (mmol/l) (age-standardized estimate)
Institutional Births (birth taken place in a facility) (%)
Existence of a national seat-belt law
Applicability of seat-belt law to all occupants
Seat-belt wearing rate (%)
Existence of national speed limits
Existence of a road safety lead agency
Existence of a universal access telephone number for pre-hospital care
Vehicle standards
Estimate of daily cigarette smoking prevalence (%)
Estimate of daily tobacco use prevalence (%)
Estimate of daily tobacco smoking prevalence (%)
Estimate of daily cigarette smoking prevalence (%) (age-standardized rate)
Estimate of current cigarette smoking prevalence (%) (age-standardized rate)
Estimate of current cigarette smoking prevalence (%)
Estimate of daily tobacco smoking prevalence (%) (age-standardized rate)
Estimate of current tobacco use prevalence (%)
Estimate of current tobacco use prevalence (%) (age-standardized rate)
Estimate of current tobacco smoking prevalence (%)
Estimate of current tobacco smoking prevalence (%) (age-standardized rate)
Estimate of daily tobacco use prevalence (%) (age-standardized rate)
Law mandates that health warnings appear on other smoked tobacco packages
Other smoked tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
Other smoked tobacco packaging and labelling must not use descriptors depicting flavours
Other smoked tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
Other smoked tobacco packaging and labelling must display qualitative information on emission yields
Emission yields must be displayed on one or more principle display areas of other smoked tobacco packaging
Display of expiry dates is prevented on other smoked tobacco packaging
Affordability - category of change since 2008 (more affordable/less affordable/no change)
Reported use of earmarked tobacco taxes
Uniform excise tax applied Yes (Uniform), No (Tiered/varying rates)
Tobacco tax revenues - valued added tax (VAT) and other sales taxes
Representativeness of most recent survey of adults
Year of latest adult prevalence survey (nonsmoked)
Age range of latest adult prevalence survey (nonsmoked)
Age range of most recent adolescent survey
Title of most recent adolescent survey
Blood Alcohol Concentration (BAC) limit for drivers
Existence of a national road safety strategy
Health warnings on other smoked tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale
Health warnings on other smoked tobacco packaging do not remove or diminish the liability of the tobacco industry
Health warnings on other smoked tobacco packaging law requires or establishes fines for violations
Ban on deceitful terms on other smoked tobacco packaging
The quit line number must appear on other smoked tobacco packaging or labelling
Plain packaging of other smoked tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited)
Health warnings on other smoked tobacco packaging must be placed at the top of the principal display areas of the package
Health warnings on other smoked tobacco packaging must not be obscured in any way including by required markings such as tax stamps
Law mandates that health warnings appear on smokeless tobacco packages
Ban on sale of smokeless tobacco products
Smokeless tobacco packaging and labelling must display qualitative information on emission yields
Plain packaging of smokeless tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited)
Display of expiry dates is prevented on smokeless tobacco packaging
Smokeless tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
Smokeless tobacco packaging and labelling must not use descriptors depicting flavours
Smokeless tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
Health warnings on smokeless tobacco packaging must include a photograph or graphic
Health warnings appear on each smokeless tobacco package and any outside packaging and labelling used in the retail sale
Health warnings on smokeless tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale
Health warnings on smokeless tobacco packaging do not remove or diminish the liability of the tobacco industry
Specific health warnings are mandated for smokeless tobacco packaging
Health warnings on smokeless tobacco packaging describe the harmful effects of tobacco use on health
Number of health warnings approved by the law for smokeless tobacco packaging
Health warnings on smokeless tobacco packaging law requires or establishes fines for violations
Percentage of principal display area mandated to be covered by health warnings - front and back of smokeless tobacco packaging
Ban on deceitful terms on smokeless tobacco packaging
Emission yields must be displayed on one or more principle display areas of smokeless tobacco packaging
Percentage of principal display area mandated to be covered by health warnings - back of smokeless tobacco packaging
Font style, font size and colour of health warnings are mandated for smokeless tobacco packaging
Health warnings on smokeless tobacco packaging must be rotated
Percentage of principal display area mandated to be covered by health warnings - front of smokeless tobacco packaging
Health warnings on smokeless tobacco packaging must be placed at the top of the principal display areas of the package
Health warnings on smokeless tobacco packaging must not be obscured in any way including by required markings such as tax stamps
Health warnings on smokeless tobacco packaging must be written in the principal language(s) of the country
Percentage of principal display area mandated to be covered by health warnings - front of cigarette packaging
Hospital beds (per 10 000 population)
Number of new HIV infections
Estimated number of people (all ages) living with HIV
Reported number of people receiving antiretroviral therapy
Number of deaths due to HIV/AIDS
Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine)  for preventing mother-to-child transmission
Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission
Reported number of children receiving antiretroviral therapy
Prevalence of HIV among adults aged 15 to 49 (%)
Estimated antiretroviral therapy coverage among people living with HIV (%)
Estimated number of children needing antiretroviral therapy based on WHO methods
Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods
Most sold brand of cigarettes - currency reported
Most sold brand of cigarettes - price in currency reported
Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)
Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%)
Hepatitis B (HepB3) immunization coverage among 1-year-olds (%)
Hib (Hib3) immunization coverage among 1-year-olds (%)
BCG immunization coverage among 1-year-olds (%)
Polio (Pol3) immunization coverage among 1-year-olds (%)
Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%)
New HIV infections (per 1000 uninfected population)
Tuberculosis effective treatment coverage (%)
New child (less than 15 years of age) leprosy cases rate per 1 000 000 population of children
Number of under-five deaths
Compliance with smoke-free indoor offices law (score)
Ban on sale of duty-free or excise-free cigarettes
Specific tax component automatically adjusted for inflation (or other)
Retail price used as base of ad valorem component in ad valorem or mixed excise regime (or retail price exclusive of VAT)
Greater reliance on specific tax  in mixed excise regime
A minimum price policy is implemented
Tobacco tax revenues - total revenues
Age range of most recent survey of adults
Title of most recent survey of adults
Name of latest adult prevalence survey (nonsmoked)
Representation of latest adult prevalence survey (nonsmoked)
Year of most recent adolescent survey
Year of latest youth prevalence survey (nonsmoked)
Representation of latest youth prevalence survey (nonsmoked)
Maximum speed limits
Law requires helmet to be fastened
Applicability of national motorcycle helmet law to all occupants
Existence of a national drink-driving law
Definition of drink-driving by BAC
Attribution of road traffic deaths to alcohol (%)
The quit line number must appear on smokeless tobacco packaging or labelling
Existence of a national child-restraint law
Availability of funding for national road safety strategy
Premium brand of cigarettes - price in currency reported
Status of yaws endemicity
Number of infant deaths
Estimated antiretroviral therapy coverage among children
Cheapest brand of cigarettes - price in currency reported
Number of neonatal deaths
Infant mortality rate (probability of dying between birth and age 1 per 1000 live births)
Under-five mortality rate (probability of dying by age 5 per 1000 live births)
Neonatal mortality rate (per 1000 live births)
Number of reported cases of poliomyelitis by wild poliovirus (WPV)
Deaths due to tuberculosis among HIV-negative people (per 100 000 population)
Incidence of tuberculosis (per 100 000 population per year)
Tuberculosis treatment coverage
New cases tested for RR-/MDR-TB (%)
Previously treated cases tested for RR-/MDR-TB (%)
Treatment success rate for patients treated for MDR-TB (%)
Cases started on MDR-TB treatment
Treatment success rate: new TB cases
Treatment success rate: previously treated TB cases
Treatment success rate: HIV-positive TB cases
Number of incident tuberculosis cases
Incidence of tuberculosis (per 100 000 population) (HIV-positive cases)
Number of incident tuberculosis cases,  (HIV-positive cases)
Number of deaths due to tuberculosis, excluding HIV
TB patients with known HIV status (%)
Tested TB patients HIV-positive (%)
New or unknown treatment history cases: Pulmonary, clinically diagnosed
New cases: extrapulmonary
New or unknown treatment history cases: Pulmonary, bacteriologically confirmed
New cases: Pulmonary, smear-negative/unknown/not done and other new cases
New cases: Pulmonary, smear-positive
Treatment history unknown
Previously treated  cases, excluding relapse
Relapse cases (pre-2013 definition)
HIV-positive TB patients on ART (antiretroviral therapy) (%)
Relapse cases: Pulmonary, clinically diagnosed
Relapse cases: extrapulmonary
Relapse cases: Pulmonary, bacteriologically confirmed
Confirmed cases of RR-/MDR-TB
Stillbirth rate (per 1000 total births)
UHC index of service coverage (SCI)
Existence of national radon action plan
Radon in national drinking-water regulations
Reference level for dwellings (Bq/m3)
Radon concentration measurements for new buildings
Radon concentration measurements for existing buildings
Financial support provided for mitigation (existing dwellings)
Official standards/guidelines for prevention/mitigation
Inclusion of radon in different national strategies
Diphtheria - number of reported cases
Japanese encephalitis - number of reported cases
Pertussis - number of reported cases
Total tetanus - number of reported cases
Estimated number of MDR/RR-TB incident cases
Existence of national reference level for buildings with high public occupancy
Reference level for buildings with high public occupancy (Bq/m3)
Existence of national reference level for workplaces
Reference level for workplaces (Bq/m3)
Existence of official protocols for radon measurements
Inclusion of radon education for building professionals
Existence of national radon risk communication strategy
Inclusion of radon measurements in property transactions
Yellow fever - number of reported cases
Mumps - number of reported cases
Congenital Rubella Syndrome - number of reported cases
Neonatal tetanus - number of reported cases
Total rubella - number of reported cases
Measles - number of reported cases
National radon concentration levels
Existence of national radon database
Data in national radon database
IHR Coordination and National IHR Focal Point Functions
Zoonotic Events and the Human-animal Interface
Human Resources
National Health Emergency Framework
Radiation Emergencies
Life expectancy at birth (years)
Healthy life expectancy (HALE) at birth (years)
Life expectancy at age 60 (years)
Healthy life expectancy (HALE) at age 60 (years)
Number of incident tuberculosis cases in children aged 0 - 14
Existence of national radon regulations
Radon in building regulations for new buildings
Radon concentration measurements for workplaces
Authorization/accreditation required for official radon measurement providers
Mandatory preventive measures (new buildings)
Mandatory mitigation measures if legal value is exceeded (existing buildings)
Legislation and Financing
Food Safety
Health Service Provision
Points of Entry
Chemical Events
nMx - age-specific death rate between ages x and x+n
ndx - number of people dying between ages x and x+n
Existence of national radon map
Existence of national radon action plan - Years covered
Radon in building regulations for existing buildings i.e. renovation/remodeling/major alteration
Existence of national reference level for dwellings
Authorization required for prevention/mitigation service providers
Existence of training for mitigation providers
Existence of any subnational radon activity
Risk Communication
nqx - probability of dying between ages x and x+n
lx - number of people left alive at age x
Existence of any national radon activity
Existence of national radon survey(s)
nLx - person-years lived between ages x and x+n
Tx - person-years lived above age x
ex - expectation of life at age x
Population with primary reliance on clean fuels and technologies for cooking (in millions)
Proportion of population with primary reliance on clean fuels and technologies for cooking (%)
Population with primary reliance on polluting fuels and technologies for cooking (in millions)
Proportion of population with primary reliance on polluting fuels and technologies for cooking (%)
Current health expenditure (CHE) per capita in PPP int$
Current health expenditure (CHE) per capita in US$
Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%)
External health expenditure (EXT) per capita in PPP int$
External health expenditure (EXT) per capita in US$
External health expenditure (EXT) as percentage of current health expenditure (CHE) (%)
Domestic general government health expenditure (GGHE-D) per capita in PPP int$
Domestic general government health expenditure (GGHE-D) per capita in US$
Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE) (%)
Domestic general government health expenditure (GGHE-D) as percentage of gross domestic product (GDP) (%)
Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%)
Out-of-pocket expenditure (OOP) per capita in PPP int$
Out-of-pocket expenditure (OOP) per capita in US$
Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%)
Domestic private health expenditure (PVT-D) per capita in PPP int$
Domestic private health expenditure (PVT-D) per capita in US$
Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%)
Status of endemicity of cutaneous leishmaniasis
Status of endemicity of visceral leishmaniasis
Age-standardized suicide rates (per 100 000 population)
Total NCD Deaths (in thousands)
Probability (%) of dying between age 30 and exact age 70 from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease
Estimated number of road traffic deaths
Estimated road traffic death rate (per 100 000 population)
Number of deaths attributed to non-communicable diseases, by type of disease and sex
Mortality rate attributed to unintentional poisoning (per 100 000 population)
Crude suicide rates (per 100 000 population)
Estimates of number of homicides
Estimates of rates of homicides per 100 000 population
Age-standardized NCD mortality rate  (per 100 000 population)
Physiotherapists (number)
Nursing and midwifery personnel  (number)
Dental Prosthetic Technicians (number)
Midwifery personnel (number)
Nursing personnel (number)
Medical doctors not further defined (number)
Specialist medical practitioners (number)
Medical doctors (number)
Generalist medical practitioners (number)
Medical doctors (per 10 000 population)
Nursing and midwifery personnel (per 10 000 population)
Medical doctors (%)
Pharmacists (number)
Dentists (number)
Dentists (per 10 000 population)
Pharmacists  (per 10 000 population)
NLIS: Population using improved drinking-water sources (%)
NLIS: Population using improved sanitation facility (%)
Population below the international poverty line (%)
Nutrition Governance score
Maternity protection: Compliance with international labour standards
GDP per capita annual growth rate (%)
Reported number of people requiring interventions against NTDs
Women of reproductive age (15−49 years) who are married or in-union who have their need for family planning satisfied with modern methods (%), UNPD
Premature deaths due to noncommunicable diseases (NCD) as a proportion of all NCD deaths (%)
Births attended by skilled health personnel (%)
Adolescent birth rate (per 1000 women aged 15-19 years)
Girls aged 15 years old that received the recommended doses of HPV vaccine (%)
Prevalence of anaemia in children aged 6–59 months (%)
Number of children aged 6–59 months with anaemia (thousands)
Number of women of reproductive age (aged 15-49 years) with anaemia (thousands)
Number of non-pregnant women (aged 15-49 years) with anaemia (thousands)
Number of pregnant women (aged 15-49 years) with anaemia (thousands)
Births in baby-friendly facilities (%)
Alcohol, total per capita (15+) consumption (in litres of pure alcohol) (SDG Indicator 3.5.2)
Best-practice policy implemented for industrially produced trans-fatty acids (TFA) (Y/N)
Prevalence of anaemia in pregnant women (aged 15-49) (%)
Prevalence of anaemia in non-pregnant women (aged 15-49) (%)
Prevalence of anaemia in women of reproductive age (aged 15-49) (%)
Mortality rate for 5-14 year-olds (probability of dying per 1000 children aged 5-14 years)
Status of elimination of trachoma as a public health problem
Legally-binding controls on lead paint
Dental Assistants and Therapists (number)
International Code on Marketing of Breast-milk Substitutes: Legal status of the Code
Proportion of ever-partnered women and girls aged 15–49 years subjected to physical and/or sexual violence by a current or former intimate partner in their lifetime
Proportion of ever-partnered women and girls aged 15–49 years subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months
